Inhibition of platelet function with synthetic peptides designed to be high-affinity antagonists of fibrinogen binding to platelets.
about
Selection and structure of ion-selective ligands for platelet integrin alpha IIb(beta) 3Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor.Agkistrodon piscivorus piscivorus platelet aggregation inhibitor: a potent inhibitor of platelet activation.Modulation of polymorphonuclear leukocyte microbicidal activity and oxidative metabolism by fibrinogen degradation products D and E.Staphylococcus aureus induces platelet aggregation via a fibrinogen-dependent mechanism which is independent of principal platelet glycoprotein IIb/IIIa fibrinogen-binding domainsRGDV peptide selectively inhibits platelet-dependent thrombus formation in vivo. Studies using a baboon model.The human platelet fibrinogen receptor: clinical and therapeutic significance.Fibronectin receptors of phagocytes. Characterization of the Arg-Gly-Asp binding proteins of human monocytes and polymorphonuclear leukocytes.Adhesive interactions of platelets and their blockade.Blood elements at surfaces: platelets.Human fibrinogen.Biological activities of a synthetic peptide composed of two unlinked domains from a retroviral transmembrane protein sequence.Tetrafibricin, a novel non-peptide fibrinogen receptor antagonist, induces conformational changes in glycoprotein IIb/IIIa.Regulation of ligand binding to glycoprotein IIb-IIIa (integrin alpha IIb beta 3) in isolated platelet membranes.A new model of dual interacting ligand binding sites on integrin alphaIIbbeta3.Binding of von Willebrand factor to glycoproteins Ib and IIb/IIIa complex: affinity is related to multimeric size.Ligand binding to integrin alphaIIbbeta3 is dependent on a MIDAS-like domain in the beta3 subunit.A novel peptide motif for platelet fibrinogen receptor recognition.
P2860
Q27636935-61545FC5-6BCC-45D8-BE17-432182300434Q33749366-5612E78B-E2C1-4D5E-8097-EDD48456E112Q34313515-4FC39A2A-20A5-41B0-9A29-A454B3A4E5F3Q34574739-4E459043-B5FB-40E1-9767-CED6874678CBQ35438892-CBA44A87-ECF4-42C0-A4C6-41C316BA5646Q35814524-565E7AB1-A786-4BA3-A0EC-5C1E176D8CD8Q35898379-505E1AD0-F2F1-4590-BE42-8C3E317CC930Q36354693-0271D12A-D5A9-4371-9DA6-54BCB3000EA3Q37711758-3C936A4B-987E-4B76-B98C-C0FE5114BD76Q39184469-80712A9F-3FDD-450A-94E0-3E7FACECB5DBQ39641908-57892645-92C2-44C3-B956-289F74A1991EQ40108371-E18DE11C-9B1C-4DAC-BB87-655B319704DDQ42160889-23D05A3C-398C-45C6-9A46-C26AC293147AQ42483407-79621B76-CFAE-49A5-9447-8797063A86D9Q45171116-479B8AA0-C1AA-45A6-B2EA-19BD0EFA6320Q45884940-E50AC79F-D9D0-45D5-BFA2-4B2A96396971Q46298719-33B85015-880A-4A41-B9AD-6E3218DF1E83Q46560846-50BE3CFB-2684-4920-8C08-74DF7ADCC213
P2860
Inhibition of platelet function with synthetic peptides designed to be high-affinity antagonists of fibrinogen binding to platelets.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 1986
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Inhibition of platelet functio ...... brinogen binding to platelets.
@en
Inhibition of platelet functio ...... brinogen binding to platelets.
@nl
type
label
Inhibition of platelet functio ...... brinogen binding to platelets.
@en
Inhibition of platelet functio ...... brinogen binding to platelets.
@nl
prefLabel
Inhibition of platelet functio ...... brinogen binding to platelets.
@en
Inhibition of platelet functio ...... brinogen binding to platelets.
@nl
P2093
P2860
P356
P1476
Inhibition of platelet functio ...... brinogen binding to platelets.
@en
P2093
R A Houghten
S R Russell
T S Zimmerman
Z M Ruggeri
P2860
P304
P356
10.1073/PNAS.83.15.5708
P407
P577
1986-08-01T00:00:00Z